CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-24 | CAUSEY CHRISTOPHER Director | Sale | −1,000 | $440.00 | $440K | 4,865 |
| 2025-09-24 | CAUSEY CHRISTOPHER Director | Exercise or conversion · Stock Option | −1,000 | 9,320 | ||
| 2025-09-24 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-09-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,316 | $433.77 | $1.4M | 814 |
| 2025-09-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −684 | $435.84 | $298K | 130 |
| 2025-09-24 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 242,000 | ||
| 2025-09-23 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-09-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,000 | $416.51 | $833K | 2,130 |
| 2025-09-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,000 | $419.79 | $840K | 130 |
| 2025-09-23 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 246,000 | ||
| 2025-09-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +14,625 | $135.42 | $2.0M | 14,625 |
| 2025-09-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −14,625 | $416.35 | $6.1M | 0 |
| 2025-09-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +7,875 | $146.03 | $1.1M | 7,875 |
| 2025-09-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −7,875 | $416.35 | $3.3M | 0 |
| 2025-09-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −14,625 | 129,000 | ||
| 2025-09-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −7,875 | 33,250 | ||
| 2025-09-22 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-09-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,000 | $416.72 | $833K | 2,130 |
| 2025-09-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,000 | $417.89 | $836K | 130 |
| 2025-09-22 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 250,000 |
Page 199 of 214 · 4,273 trades